Nord-Trondelag Hospital Trust
Levanger, Nord-Trondelag, 7600, Norway
NCT Number: NCT00326222
The purpose of this randomised open study is to examine the effect of self-management program for diabetes patients.
Looking for future studies?
Notify Me18 year–90 year
All sexes
Interventional
Not applicable
Levanger, Nord-Trondelag, 7600, Norway
The primary aim in this study is HbA1c in addition to secondary aims like quality of life and coping.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Self-management group education
Other names: Self-management
Time frame: Baseline, 6, and 12 mds
Time frame: Baseline, 6, and 12 mds
Time frame: Baseline, 6, and 12 mds
Time frame: Baseline, 6, and 12 mds
Time frame: Baseline, 6, and 12 mds
Time frame: Baseline, 6, and 12 mds
Time frame: Baseline, 6, and 12 mds
Time frame: Baseline, 6, and 12 mds
Time frame: Baseline, 6, and 12 mds
Time frame: Baseline, 6, and 12 mds
Time frame: Baseline, 6, and 12 mds
Time frame: Baseline, 6, and 12 mds
Time frame: Baseline, 6, and 12 mds
Time frame: Baseline, 6, and 12 mds
Time frame: Baseline, 6, and 12 mds
Norwegian University of Science and Technology
Other
Patient Education in NorthTrondelag Hospital Trust - Interventions, Effects and Patient Experience
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00038727
Body Weight, CVD
Rockville, Maryland, United States
View Trial DetailsNCT06029517
Arterial Occlusive Diseases, Arteriosclerosis
Buffalo, New York, United States
View Trial DetailsNCT01934660
Cardiovascular Disease, Cardiovascular Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT07728162
Diabetes Mellitus, Disease Attributes
Bolu, Turkey (Türkiye)
View Trial Details